Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial

INTRODUCTION: Psilocybin-assisted therapy may be a new treatment for major depressive disorder (MDD), with encouraging data from pilot trials. In this trial (short name: PsiDeR) we aimed to test the feasibility of a parallel-group, randomised, placebo-controlled design. The primary outcomes in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Rucker, James, Jafari, Hassan, Mantingh, Tim, Bird, Catherine, Modlin, Nadav Liam, Knight, Gemma, Reinholdt, Frederick, Day, Camilla, Carter, Ben, Young, Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Mental Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638462/
https://www.ncbi.nlm.nih.gov/pubmed/34853114
http://dx.doi.org/10.1136/bmjopen-2021-056091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638462/
https://www.ncbi.nlm.nih.gov/pubmed/34853114
http://dx.doi.org/10.1136/bmjopen-2021-056091

Ejemplares similares